These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 965083)

  • 41. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP; de Tribolet N; Zander E
    Schweiz Rundsch Med Prax; 1977 Aug; 66(32):1020-6. PubMed ID: 556440
    [No Abstract]   [Full Text] [Related]  

  • 42. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome].
    Russo R; Schena FP; Colombo Pirola L
    Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of diuretics in preventing ascites recurrence.
    Arrigoni A; Andriulli A; Gindro T; Verme G
    Br J Clin Pract; 1988 Mar; 42(3):116-20. PubMed ID: 3207572
    [No Abstract]   [Full Text] [Related]  

  • 44. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R
    Schweiz Rundsch Med Prax; 1975 Nov; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension].
    Morabito S; Fabiano M; Puliti M; Palumbo R; Marinelli R; Simonetti BM; Pierucci A
    Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluid and electrolyte concerns in intestinal surgical procedures.
    McConnell EA
    Nurs Clin North Am; 1987 Dec; 22(4):853-60. PubMed ID: 3317289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrolyte content of salt-replacement seasonings.
    Ahern DA; Kaley LA
    J Am Diet Assoc; 1989 Jul; 89(7):935-8. PubMed ID: 2745911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Influencing postoperative water-electrolyte imbalance with spironolactone (verospirone)].
    Merrem B; Rost W
    Zentralbl Neurochir; 1974; 35(3):193-9. PubMed ID: 4470306
    [No Abstract]   [Full Text] [Related]  

  • 50. [Normal value of electrolytes in the gastric juice].
    Shuhama T; Ziliotto A; Campos A; Sayon R; Goveia EG; Netto AS; Kunzle JE
    G E N; 1976; 30(1-2):61-70. PubMed ID: 829081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances.
    Kraus MA
    Semin Dial; 2009; 22(2):137-40. PubMed ID: 19426416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of hypercalcemia on serum concentrations of magnesium, potassium, and phosphate and urinary excretion of electrolytes in horses.
    Toribio RE; Kohn CW; Rourke KM; Levine AL; Rosol TJ
    Am J Vet Res; 2007 May; 68(5):543-54. PubMed ID: 17472456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrolyte determinations in normal, denervated, and defunctionalized dog bladders.
    Wein AJ; Perkins JH; Rohner T; Schoenberg HW
    Invest Urol; 1967 May; 4(6):608-14. PubMed ID: 6024108
    [No Abstract]   [Full Text] [Related]  

  • 54. [Essential arterial hypertension. A therapeutic proposal].
    Di Veroli C; Iugoli AR
    Arch Sci Med (Torino); 1981; 138(3):355-60. PubMed ID: 6119065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
    Bos R; Mougenot N; Médiani O; Vanhoutte PM; Lechat P
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1160-6. PubMed ID: 14764658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
    Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
    Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of surgical procedure on salivary electrolytes.
    Abelson DC; Wotman S; Mandel ID; Marcus L; Waldo AL
    J Oral Med; 1974; 29(2):41-4. PubMed ID: 4524265
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of potassium-canrenoate in the 3H-noradrenaline uptake and metabolism of the rat heart.
    Préda I; Sebeszta M; Antalóczy Z
    Arzneimittelforschung; 1980; 30(3):436-8. PubMed ID: 7387752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart failure and electrolyte disturbances.
    Schwinger RH; Erdmann E
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):315-25. PubMed ID: 1507935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [EEG changes following spirolactone treatment (author's transl)].
    Simon O; Mertin J; Brass B
    Med Klin; 1978 Mar; 73(13):470-3. PubMed ID: 634207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.